Antibodies have been applied for clinical therapies with high specificity and affinity for a long period. Creative Biolabs has successfully developed universal antibody platforms and several efficient strategies to provide a series of anti-glycan antibodies products and services based on abundant experience and first-in-class technologies. We are capable to provide a wide spectrum of services based on specific demands of customers with the highest quality and the most satisfactory outcomes.
As everyone knows, the use of antibodies in treating disease has made great achievements in recent years. Antibodies have been extensively demonstrated to be effective in the treatment of inflammatory disease, infectious diseases, more importantly, for cancers. Although the development and availability of anti-glycan antibodies are relatively lagging behind of anti-protein antibodies or anti-peptide antibodies, anti-glycan antibodies also display preferably therapeutic effect due to the specific and targeting binding to carbohydrates-based antigens, on which carbohydrates are another major targets of clinic diagnostics and therapeutics.
Applying anti-glycan antibodies for disease therapies mainly based on the specificity and targeting properties. Anti-glycan antibodies specifically bind to cell surface or some carbohydrate to further stimulate the immune response attack those antigens in vivo. This characteristic of anti-glycan antibodies can be utilized in treatments of immune-related diseases, such as inflammatory and infections. Different cells with different functions present different carbohydrates or glycan chains on the surface of cell membranes. And anti-glycan antibody is the specific agent that can be targeted to specific cell surfaces. Therefore, anti-glycan antibodies are potential to be developed as long-sought vehicles or carriers for the targeted drug delivery, which provides a new perspective to the targeted therapy of cancers as powerful tools both by radiotherapy and chemotherapy. With the deepening of research, anti-glycan antibodies will perform a significant role in the treatment of various human diseases as with current well-developed anti-protein antibodies.
Fig.1 Applications of anticarbohydrate antibodies in research and clinical therapy (Sterner, 2016).
Anti-glycan antibodies are useful tools with wide applications not only in laboratory experiments but also in clinical disease treatments. As a world's leading biotechnology company and scientific research service provider, Creative Biolabs has constructed several universal and powerful platforms to better serve our global clients. During the past few years, our professional teams have successfully served thousands of customers with a strong background of knowledge in both antibodies and related diseases. In a word, in addition to the application for diseases therapies, we are able to offer a series of comprehensive one-stop services about anti-glycan antibodies to promote your research or projects, which include:
For details, please directly contact us or send us an inquiry. Our seasoned scientists are pleased to provide the most suitable solution for our customer’s satisfaction.
Reference:
